Maryam Pourabdollah
Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Targeting CD47/TNFAIP8 by miR-155 overcomes drug resistance and inhibits tumor growth through induction of phagocytosis and apoptosis in multiple myeloma.
Journal: Haematologica
Published: November 28, 2019
MARCKS inhibition cooperates with autophagy antagonists to potentiate the effect of standard therapy against drug-resistant multiple myeloma.
Journal: Cancer letters
Published: November 18, 2019
EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies.
Journal: Biomarker research
Published: August 31, 2018
Coexistence of multiple myeloma and Paget disease of bone.
Journal: Blood
Published: September 02, 2017
Acute myeloid leukemia with mutated NPM1 demonstrating multilineage dysplasia and marked thrombocytosis.
Journal: British journal of haematology
Published: July 06, 2017
Re-evaluation of acute erythroid leukemia according to the 2016 WHO classification.
Journal: Leukemia research
Published: June 21, 2017
Myelodysplastic syndrome with excess blasts-2 associated with erythroid predominance.
Journal: Blood
Published: February 18, 2017
Plasma cell neoplasm with plasmablastic morphology mimicking acute leukemia.
Journal: Blood
Published: January 07, 2017
Synchronous T lymphoblastic lymphoma and myeloid neoplasm with PDGFRA rearrangement.
Journal: International journal of laboratory hematology
Published: December 26, 2016
High IKZF1/3 protein expression is a favorable prognostic factor for survival of relapsed/refractory multiple myeloma patients treated with lenalidomide.
Journal: Journal of hematology & oncology
Published: September 16, 2016
Showing 1-12 of 12
Last Updated: 09/26/2026